202 related articles for article (PubMed ID: 32246859)
41. Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.
Ampadu HH; Hoekman J; de Bruin ML; Pal SN; Olsson S; Sartori D; Leufkens HG; Dodoo AN
Drug Saf; 2016 Apr; 39(4):335-45. PubMed ID: 26754924
[TBL] [Abstract][Full Text] [Related]
42. COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database.
Dernoncourt A; Schmidt J; Duhaut P; Liabeuf S; Gras-Champel V; Masmoudi K; Bennis Y; Batteux B
Fundam Clin Pharmacol; 2022 Feb; 36(1):199-209. PubMed ID: 33973280
[TBL] [Abstract][Full Text] [Related]
43. SGLT2 inhibitors associated pancreatitis: signal identification through disproportionality analysis of spontaneous reports and review of case reports.
Palapra H; Viswam SK; Kalaiselvan V; Undela K
Int J Clin Pharm; 2022 Dec; 44(6):1425-1433. PubMed ID: 36224513
[TBL] [Abstract][Full Text] [Related]
44. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
45. Tamoxifen and the risk of Parkinsonism: a case/non-case study.
Montastruc F; Khosrow-Khavar F; de Germay S; Renoux C; Rousseau V; Durrieu G; Montastruc M; Rascol O; Sommet A; Lapeyre-Mestre M; Benevent J; Montastruc JL
Eur J Clin Pharmacol; 2018 Sep; 74(9):1181-1184. PubMed ID: 29862427
[TBL] [Abstract][Full Text] [Related]
46. Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: a pharmacovigilance-pharmacodynamic/pharmacokinetic assessment through an analysis of the vigibase®.
Carnovale C; Mazhar F; Arzenton E; Moretti U; Pozzi M; Mosini G; Leoni O; Scatigna M; Clementi E; Radice S
Expert Opin Drug Saf; 2019 Nov; 18(11):1099-1108. PubMed ID: 31519110
[No Abstract] [Full Text] [Related]
47. Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase.
Vabre C; Johnson K; Montastruc F; Vezzosi D; Yu OH; Renoux C
Eur J Clin Pharmacol; 2023 Mar; 79(3):383-388. PubMed ID: 36602591
[TBL] [Abstract][Full Text] [Related]
48. Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in vietnamese spontaneous adverse drug reaction database: A subgroup approach to disproportionality analysis.
Nguyen KD; Tran TN; Nguyen MT; Nguyen HA; Nguyen HA; Vu DH; Nguyen VD; Bagheri H
J Clin Pharm Ther; 2019 Feb; 44(1):69-77. PubMed ID: 30129156
[TBL] [Abstract][Full Text] [Related]
49. Drug-Induced Anaphylaxis in a Vietnamese Pharmacovigilance Database: Trends and Specific Signals from a Disproportionality Analysis.
Nguyen KD; Nguyen HA; Vu DH; Le TT; Nguyen HA; Dang BV; Nguyen TN; Nguyen DH; Nguyen TB; Montastruc JL; Bagheri H
Drug Saf; 2019 May; 42(5):671-682. PubMed ID: 30478823
[TBL] [Abstract][Full Text] [Related]
50. Cardiovascular Toxicities Associated With Ibrutinib.
Salem JE; Manouchehri A; Bretagne M; Lebrun-Vignes B; Groarke JD; Johnson DB; Yang T; Reddy NM; Funck-Brentano C; Brown JR; Roden DM; Moslehi JJ
J Am Coll Cardiol; 2019 Oct; 74(13):1667-1678. PubMed ID: 31558250
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.
Cornet L; Khouri C; Roustit M; Guignabert C; Chaumais MC; Humbert M; Revol B; Despas F; Montani D; Cracowski JL
Eur Respir J; 2019 May; 53(5):. PubMed ID: 30846469
[TBL] [Abstract][Full Text] [Related]
52. Hypertension induced by serotonin reuptake inhibitors: analysis of two pharmacovigilance databases.
Humbert X; Fedrizzi S; Chrétien B; Sassier M; Bagheri H; Combret S; Drici MD; Le Bas F; Puddu PE; Alexandre J
Fundam Clin Pharmacol; 2019 Jun; 33(3):296-302. PubMed ID: 30489655
[TBL] [Abstract][Full Text] [Related]
53. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
Sato K; Mano T; Iwata A; Toda T
J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
[TBL] [Abstract][Full Text] [Related]
54. Drug-related catatonia in youths: real-world insights from the WHO Safety Database.
Merino D; Gérard AO; Lavrut T; Askenazy F; Thümmler S; Montastruc F; Drici MD
Eur Child Adolesc Psychiatry; 2024 May; 33(5):1383-1393. PubMed ID: 37308606
[TBL] [Abstract][Full Text] [Related]
55. Mapping endocrine toxicity spectrum of immune checkpoint inhibitors: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.
Bai X; Lin X; Zheng K; Chen X; Wu X; Huang Y; Zhuang Y
Endocrine; 2020 Sep; 69(3):670-681. PubMed ID: 32507965
[TBL] [Abstract][Full Text] [Related]
56. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
[TBL] [Abstract][Full Text] [Related]
57. Drug-induced depressive symptoms: An update through the WHO pharmacovigilance database.
Li J; Zelmat Y; Storck W; Laforgue EJ; Yrondi A; Balcerac A; Sommet A; Montastruc F
J Affect Disord; 2024 Apr; 350():452-467. PubMed ID: 38244800
[TBL] [Abstract][Full Text] [Related]
58. Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems.
Raschi E; Parisotto M; Forcesi E; La Placa M; Marchesini G; De Ponti F; Poluzzi E
Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1098-1107. PubMed ID: 29174026
[TBL] [Abstract][Full Text] [Related]
59. Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality.
Verdel BM; van Puijenbroek EP; Souverein PC; Leufkens HG; Egberts AC
Drug Saf; 2008; 31(10):877-84. PubMed ID: 18759511
[TBL] [Abstract][Full Text] [Related]
60. Immune checkpoint inhibitor-associated pituitary adverse events: an observational, retrospective, disproportionality study.
Bai X; Chen X; Wu X; Huang Y; Zhuang Y; Chen Y; Feng C; Lin X
J Endocrinol Invest; 2020 Oct; 43(10):1473-1483. PubMed ID: 32239475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
